Liquid Biopsy Market - Global Industry Analysis
Liquid Biopsy Market by Target Analyte (Circulating Tumor Cells (Ctcs), Circulating Tumor DNA (CtDNA), Exosomes, Nucleosomes, and Other Biomarkers), by Analytical (Molecular, Proteomic, and Histology/Imaging), by Application (Routine Screening, Patient Work-Up, Early-Stage Disease, and Late-Stage/Metastatic Disease), by Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, Brain Cancer, and Others), by Sample (Blood, Urine, and Others), and by End-User (Hospitals, Research Laboratories, Academia, and Research Centers): Global Industry Perspective Comprehensive Analysis, and Forecast, 2018–2025
Published Date: 09-May-2019Pharmaceutical
Category: Report Format : PDF
Report Code: ZMR-884
Status : Published
Global liquid biopsy market expected to generate approximately USD 12,062 million by 2025, at a CAGR of slightly above 38.3% between 2019 and 2025. A biopsy is a tissue or cell sample taken from any part of the human body, which is sent to the lab for examining various disease types.